Belite Bio Inc Made Headway
Mon, Jun 13, 2022 at 05:30 PM
Belite Bio Inc (BLTE:NASDAQ) shot up at $22.75, representing a gain of 22.9%. On Fri, Jun 10, 2022, BLTE:NASDAQ hit a New 2-Week High of $18.51. From Tue, May 31, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days
About Belite Bio Inc (BLTE:NASDAQ)
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic...
Top 10 Gainers:
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- Day One Biopharmaceuticals Inc. (DAWN:NASDAQ), 125.98%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 88.32%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 68.75%
- OptiNose, Inc. (OPTN:NASDAQ), 41.08%
- AeroClean Technologies Inc. (AERC:NASDAQ), 38%
- Cyngn Inc. (CYN:NASDAQ), 34.43%
- Eliem Therapeutics Inc (ELYM:NASDAQ), 24.19%
- Ekso Bionics Holdings, Inc. (EKSO:NASDAQ), 23.33%
- Belite Bio Inc (BLTE:NASDAQ), 22.91%